 |
Researchers have found a new explanation for the effects of Copaxone® (glatiramer acetate, Teva Pharmaceuticals), a treatment approved for relapsing-remitting multiple sclerosis.
Nitin J. Karandikar, MD, PhD (University of Texas Southwestern Medical Center, Dallas), a Harry Weaver Neuroscience Scholar of the National MS Society, and colleagues report their findings in the Journal of Immunology (2006 Jun 1;176(11):7119-29).
Copaxone is a synthetic compound made up of four amino acids (the building blocks of proteins) that are found in myelin. This drug is thought to stimulate one type of T cell (called a CD4+ T cell) in the body’s immune system to change from pro-inflammatory agents that attack the brain and spinal cord in MS, to beneficial agents that work to reduce inflammation at sites of damage in the nervous system.
To read more, please click on the link below.
Source: US National MS Society
Weblink: click here
|